0
Praxis Precision Medicines, Inc. Banner Image

Praxis Precision Medicines, Inc.

  • Ticker PRAX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Praxis Precision Medicines, Inc. Logo Image
  • 51-200 Employees
  • Based in Boston, Massachusetts
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through their proprietary smallMore molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™, using their understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across movement disorders and epilepsy, with four clinical-stage product candidates.
Praxis Precision Medicines, Inc.

Most Recent Annual Report

Praxis Precision Medicines, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Praxis Precision Medicines, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!